接受过包柔氏病原抗体检测的人和血清包柔氏病原抗体阳性者患心力衰竭的风险;一项以全国人口为基础、以登记簿为依据的匹配队列研究

IF 3.1 2区 医学 Q2 INFECTIOUS DISEASES
Malte M. Tetens , Lars Haukali Omland , Ram B. Dessau , Svend Ellermann-Eriksen , Nanna S. Andersen , Charlotte Sværke Jørgensen , Christian Østergaard , Jacob Bodilsen , Kirstine K. Søgaard , Jette Bangsborg , Alex Christian Yde Nielsen , Jens Kjølseth Møller , Ming Chen , Jesper Hastrup Svendsen , Niels Obel , Anne-Mette Lebech
{"title":"接受过包柔氏病原抗体检测的人和血清包柔氏病原抗体阳性者患心力衰竭的风险;一项以全国人口为基础、以登记簿为依据的匹配队列研究","authors":"Malte M. Tetens ,&nbsp;Lars Haukali Omland ,&nbsp;Ram B. Dessau ,&nbsp;Svend Ellermann-Eriksen ,&nbsp;Nanna S. Andersen ,&nbsp;Charlotte Sværke Jørgensen ,&nbsp;Christian Østergaard ,&nbsp;Jacob Bodilsen ,&nbsp;Kirstine K. Søgaard ,&nbsp;Jette Bangsborg ,&nbsp;Alex Christian Yde Nielsen ,&nbsp;Jens Kjølseth Møller ,&nbsp;Ming Chen ,&nbsp;Jesper Hastrup Svendsen ,&nbsp;Niels Obel ,&nbsp;Anne-Mette Lebech","doi":"10.1016/j.ttbdis.2024.102345","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Lyme borreliosis is a tick-borne disease caused by the bacterium Borrelia burgdorferi (Bb) sensu lato complex. Previous studies have suggested an association between Lyme borreliosis and heart failure, which have been suggested to be a possible manifestation of Lyme carditis. We aimed to investigate the risk of heart failure among individuals tested for serum Bb antibodies, and serum Bb seropositive individuals.</p></div><div><h3>Methods</h3><p>We performed a matched nationwide cohort study (Denmark, 1993–2020) and included 52,200 Bb seropositive individuals, and two age- and sex-matched comparison cohorts: 1) 104,400 Bb seronegative comparison cohort members, and 2) 261,000 population controls. We investigated the risk associated with 1) being tested for serum Bb antibodies, and 2) being Bb seropositive. Outcomes were: 1) a composite of heart failure, cardiomyopathy, and/or myocarditis diagnosis, and 2) redemption of cardiovascular medicine used for treatment of heart failure. We calculated short-term odds ratios (aOR) (within 1 month) and long-term hazard rates (aHR) (after 1 month) adjusted for age, sex, diabetes, pre-existing heart failure, and kidney disease.</p></div><div><h3>Results</h3><p>Compared with the population controls, individuals tested for Bb antibodies, regardless of the test result, had increased short-term risk of heart failure, cardiomyopathy, and myocarditis (aOR 8.3, 95 %CI: 6.7–10.2), and both increased short- and long-term risk of redemption of cardiovascular medicine (aOR 4.3, 95 %CI: 3.8–4.8, aHR 1.13, 95 % CI: 1.11–1.15). The Bb seropositive individuals had no increased short- or long-term risk of any outcome compared with Bb seronegative comparison cohort members.</p></div><div><h3>Conclusions</h3><p>In conclusion, Bb antibody tests seemed to be performed in the diagnostic work-up of heart failure, but Bb seropositivity was not associated with heart failure.</p></div>","PeriodicalId":49320,"journal":{"name":"Ticks and Tick-borne Diseases","volume":"15 4","pages":"Article 102345"},"PeriodicalIF":3.1000,"publicationDate":"2024-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1877959X24000384/pdfft?md5=0362cdd6b144bef6c36e06c333963d27&pid=1-s2.0-S1877959X24000384-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Risk of heart failure among individuals tested for Borrelia burgdorferi sensu lato antibodies, and serum Borrelia burgdorferi sensu lato seropositive individuals; a nationwide population-based, registry-based matched cohort study\",\"authors\":\"Malte M. Tetens ,&nbsp;Lars Haukali Omland ,&nbsp;Ram B. Dessau ,&nbsp;Svend Ellermann-Eriksen ,&nbsp;Nanna S. Andersen ,&nbsp;Charlotte Sværke Jørgensen ,&nbsp;Christian Østergaard ,&nbsp;Jacob Bodilsen ,&nbsp;Kirstine K. Søgaard ,&nbsp;Jette Bangsborg ,&nbsp;Alex Christian Yde Nielsen ,&nbsp;Jens Kjølseth Møller ,&nbsp;Ming Chen ,&nbsp;Jesper Hastrup Svendsen ,&nbsp;Niels Obel ,&nbsp;Anne-Mette Lebech\",\"doi\":\"10.1016/j.ttbdis.2024.102345\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Lyme borreliosis is a tick-borne disease caused by the bacterium Borrelia burgdorferi (Bb) sensu lato complex. Previous studies have suggested an association between Lyme borreliosis and heart failure, which have been suggested to be a possible manifestation of Lyme carditis. We aimed to investigate the risk of heart failure among individuals tested for serum Bb antibodies, and serum Bb seropositive individuals.</p></div><div><h3>Methods</h3><p>We performed a matched nationwide cohort study (Denmark, 1993–2020) and included 52,200 Bb seropositive individuals, and two age- and sex-matched comparison cohorts: 1) 104,400 Bb seronegative comparison cohort members, and 2) 261,000 population controls. We investigated the risk associated with 1) being tested for serum Bb antibodies, and 2) being Bb seropositive. Outcomes were: 1) a composite of heart failure, cardiomyopathy, and/or myocarditis diagnosis, and 2) redemption of cardiovascular medicine used for treatment of heart failure. We calculated short-term odds ratios (aOR) (within 1 month) and long-term hazard rates (aHR) (after 1 month) adjusted for age, sex, diabetes, pre-existing heart failure, and kidney disease.</p></div><div><h3>Results</h3><p>Compared with the population controls, individuals tested for Bb antibodies, regardless of the test result, had increased short-term risk of heart failure, cardiomyopathy, and myocarditis (aOR 8.3, 95 %CI: 6.7–10.2), and both increased short- and long-term risk of redemption of cardiovascular medicine (aOR 4.3, 95 %CI: 3.8–4.8, aHR 1.13, 95 % CI: 1.11–1.15). The Bb seropositive individuals had no increased short- or long-term risk of any outcome compared with Bb seronegative comparison cohort members.</p></div><div><h3>Conclusions</h3><p>In conclusion, Bb antibody tests seemed to be performed in the diagnostic work-up of heart failure, but Bb seropositivity was not associated with heart failure.</p></div>\",\"PeriodicalId\":49320,\"journal\":{\"name\":\"Ticks and Tick-borne Diseases\",\"volume\":\"15 4\",\"pages\":\"Article 102345\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2024-04-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S1877959X24000384/pdfft?md5=0362cdd6b144bef6c36e06c333963d27&pid=1-s2.0-S1877959X24000384-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ticks and Tick-borne Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1877959X24000384\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ticks and Tick-borne Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1877959X24000384","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

摘要

背景莱姆病是一种蜱媒疾病,由鲍氏包虫病(Borrelia burgdorferi,Bb)感性复合菌引起。以往的研究表明,莱姆包虫病与心力衰竭之间存在关联,而心力衰竭被认为是莱姆心肌炎的一种可能表现形式。我们的目的是调查接受血清 Bb 抗体检测的人和血清 Bb 血清阳性者患心力衰竭的风险。方法我们进行了一项匹配的全国性队列研究(丹麦,1993-2020 年),纳入了 52,200 名 Bb 血清阳性者和两个年龄与性别匹配的对比队列:1) 104,400 名 Bb 血清阴性对比队列成员,以及 2) 261,000 名人群对照。我们研究了与 1) 接受血清 Bb 抗体检测和 2) Bb 血清阳性相关的风险。研究结果包括1)心力衰竭、心肌病和/或心肌炎的综合诊断,以及 2)治疗心力衰竭的心血管药物豁免。我们计算了短期几率比(aOR)(1 个月内)和长期危险率(aHR)(1 个月后),并对年龄、性别、糖尿病、原有心力衰竭和肾脏疾病进行了调整。结果与人群对照组相比,无论检测结果如何,Bb 抗体检测者患心力衰竭、心肌病和心肌炎的短期风险都会增加(aOR:8.3,95 %CI:6.7-10.2),而心血管药物治疗的短期和长期风险都会增加(aOR:4.3,95 %CI:3.8-4.8,aHR:1.13,95 %CI:1.11-1.15)。与 Bb 血清阴性的对比队列成员相比,Bb 血清阳性者发生任何结果的短期或长期风险均未增加。结论:Bb 抗体检测似乎应在心力衰竭的诊断工作中进行,但 Bb 血清阳性与心力衰竭无关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Risk of heart failure among individuals tested for Borrelia burgdorferi sensu lato antibodies, and serum Borrelia burgdorferi sensu lato seropositive individuals; a nationwide population-based, registry-based matched cohort study

Background

Lyme borreliosis is a tick-borne disease caused by the bacterium Borrelia burgdorferi (Bb) sensu lato complex. Previous studies have suggested an association between Lyme borreliosis and heart failure, which have been suggested to be a possible manifestation of Lyme carditis. We aimed to investigate the risk of heart failure among individuals tested for serum Bb antibodies, and serum Bb seropositive individuals.

Methods

We performed a matched nationwide cohort study (Denmark, 1993–2020) and included 52,200 Bb seropositive individuals, and two age- and sex-matched comparison cohorts: 1) 104,400 Bb seronegative comparison cohort members, and 2) 261,000 population controls. We investigated the risk associated with 1) being tested for serum Bb antibodies, and 2) being Bb seropositive. Outcomes were: 1) a composite of heart failure, cardiomyopathy, and/or myocarditis diagnosis, and 2) redemption of cardiovascular medicine used for treatment of heart failure. We calculated short-term odds ratios (aOR) (within 1 month) and long-term hazard rates (aHR) (after 1 month) adjusted for age, sex, diabetes, pre-existing heart failure, and kidney disease.

Results

Compared with the population controls, individuals tested for Bb antibodies, regardless of the test result, had increased short-term risk of heart failure, cardiomyopathy, and myocarditis (aOR 8.3, 95 %CI: 6.7–10.2), and both increased short- and long-term risk of redemption of cardiovascular medicine (aOR 4.3, 95 %CI: 3.8–4.8, aHR 1.13, 95 % CI: 1.11–1.15). The Bb seropositive individuals had no increased short- or long-term risk of any outcome compared with Bb seronegative comparison cohort members.

Conclusions

In conclusion, Bb antibody tests seemed to be performed in the diagnostic work-up of heart failure, but Bb seropositivity was not associated with heart failure.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Ticks and Tick-borne Diseases
Ticks and Tick-borne Diseases INFECTIOUS DISEASES-MICROBIOLOGY
CiteScore
6.90
自引率
12.50%
发文量
185
审稿时长
6-12 weeks
期刊介绍: Ticks and Tick-borne Diseases is an international, peer-reviewed scientific journal. It publishes original research papers, short communications, state-of-the-art mini-reviews, letters to the editor, clinical-case studies, announcements of pertinent international meetings, and editorials. The journal covers a broad spectrum and brings together various disciplines, for example, zoology, microbiology, molecular biology, genetics, mathematical modelling, veterinary and human medicine. Multidisciplinary approaches and the use of conventional and novel methods/methodologies (in the field and in the laboratory) are crucial for deeper understanding of the natural processes and human behaviour/activities that result in human or animal diseases and in economic effects of ticks and tick-borne pathogens. Such understanding is essential for management of tick populations and tick-borne diseases in an effective and environmentally acceptable manner.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信